US Patent Family Members and Approved Drugs for Canada Patent: 2108692
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: CA2108692
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 5,509,905 | 2013-04-23 | insulin glargine | Sanofi-aventis U.s. Llc | LANTUS |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
